Cancer remains a significant global health challenge, with chronic inflammation often driving in tumor development and progression. , Therefore, the search for novel anti-inflammatory agents to complement conventional cancer therapies is essential. Triiptolide, a synthetic derivative of the natur

Barzolvolimab: A Novel Chance for Inflammatory Conditions? Barzolvolimab, a newly developed medicinal molecule, is creating significant attention within the scientific field. This groundbreaking antibody functions as a effective blocker of IL- 17F cytokine, a vital driver in the deve